Why Invest in Theralase Technologies?

Patented Therapeutic Medical Laser Technology

• Proven clinical technology (TLC-1000)
• Commercial therapeutic laser business and brand developed over last 17 years
• Recognized as the most effective therapeutic laser technology in the world
• Technology supported by double-blind clinical trials
• Approved by the FDA, CE and Health Canada
• Listed on the Toronto Venture Stock Exchange: TLT
• No debt
• Positive cash flow / great growth potential
• PDC cancer destruction in animals helps pay for human trials
• Patented technology destroys E. coli and Listeria bacteria  
• Competitive technical advantage (Cellular pathways: iNOS, ATP, Na+ / K+)
• Large addressable US market ($ billions)
• Future technology (Patented biofeedback technology and patented PDC cancer destruction)
• Opportunity for growth (revenue, profit)
• IP protection (multiple issued patents)
• Experienced management team (20+ years)
• Clear vision and execution strategy

Business Objectives (2011 - 2012)

• Expansion into the US market, hire experienced medical equipment sales professionals
• Seminar Series (major US cities)
• Speaking Engagements at Trade Shows
• Active educational Webinar program
• Customer Referral Program
• Partnerships with Medical and Chiropractic Colleges

Launch of TLC-2000 Biofeedback Therapeutic Laser employing a recurring revenue model
Commence TLC-3000 and PDC small animal in vivo pre-clinical trial for cancer destruction

A Sound Investment in Medical Treatment Technology

An investment in Theralase is an investment in the cutting edge of advanced medical treatment technology. A solid reputation built on advanced research and development, an experienced management team and proven patented technology make Theralase an investment with unlimited potential.


For more information please call 1-866-843-5273 or visit www.theralase.com


This posting contains forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein.